A founders guide to securing and navigating first meetings with big pharma
You’ve built something genuinely new, and you’re working up the courage to speak to a big pharma company about collaboration. But how do you get the meeting, what can you expect, and what do you propose so that a big company can act on it?
This talk is about how to get into a real partnership negotiation: how pharma works behind closed doors, how to secure your first partnering meetings, how to talk to the people you’ll meet, and how to read what they mean between the lines.
Lecturer: Anna Gran
Anna brings 15+ years of experience in pharma and biotech: a four-leaf clover of venture investor, pharma buyer, scientist, and launch lead. At Johnson & Johnson and Novo Nordisk she worked in search & evaluation, due diligence, transactions, and alliance management; and led a commercial oncology blockbuster drug launch in the Nordics.
As investor at Sound Bioventures, she evaluated investments from a future buyer’s view, a lens she now brings to biotech founders and boards in her work as an advisor. She started her career by spending nearly a decade in biomedical research in institutions in Finland and the Netherlands.
Information
- When: to
- Where: BioStock Office, Medicon Village, Lund
- Organizer: BioStock
- Language: English
Registration
Please register no later than Monday 23 November 2026